📢 Highlights from May 12 to 19 in the world of pharma and healthcare! 🗞️👀

VYUHPHARMA AbTherx CREATING CURES AbTherx and Spice Biotechnologies have launched a multi-program antibody discovery collaboration utilizing the Atlas™™ mouse platform AstraZeneca AstraZeneca's Trixeo Aerosphere has receiveed UK approval with a near-zero GWP propellant, achieving a 99.9% reduction in global warming impact for respiratory inhalers Roche The FDA has approved Roche's VENTANA MET assay, paving the way for the precise selection of NSCLC patients for AbbVie's EMRELIS (Collaboration, ADC, Phase 3) (UK, Approval, Sustainability) (FDA, Approval, NSQ-NSCLC) All logos and trademarks remain the intellectual properties of their respective owners

Connect with us

Please fill in the information below, and we'll get back to you.